HUP9904030A2 - Tiagabin felhasználása pszichotikus rendellenességek kezelésére alkalmas gyógyszer előállítására - Google Patents

Tiagabin felhasználása pszichotikus rendellenességek kezelésére alkalmas gyógyszer előállítására

Info

Publication number
HUP9904030A2
HUP9904030A2 HU9904030A HUP9904030A HUP9904030A2 HU P9904030 A2 HUP9904030 A2 HU P9904030A2 HU 9904030 A HU9904030 A HU 9904030A HU P9904030 A HUP9904030 A HU P9904030A HU P9904030 A2 HUP9904030 A2 HU P9904030A2
Authority
HU
Hungary
Prior art keywords
tiagabine
production
psychotic disorders
pharmaceutical against
against psychotic
Prior art date
Application number
HU9904030A
Other languages
English (en)
Inventor
Anders Fink-Jensen
Original Assignee
Novo Nordisk A/S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S. filed Critical Novo Nordisk A/S.
Publication of HUP9904030A2 publication Critical patent/HUP9904030A2/hu
Publication of HUP9904030A3 publication Critical patent/HUP9904030A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Abstract

A találmány tárgya a tiagabin (kémiai nevén: N-(4,4-di(3-metil-tien-2-il)-bűt-3-enil)-nipekőtinsav R-izőmerje) vagy valamely gyógyászatilagelfőgadható sójának felhasználása pszichőtikűs rendellenességekkezelésre alkalmas gyógyszer előállítására. ŕ
HU9904030A 1996-07-31 1997-07-25 Use of tiagabine for production of pharmaceutical against psychotic disorders HUP9904030A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK82496 1996-07-31

Publications (2)

Publication Number Publication Date
HUP9904030A2 true HUP9904030A2 (hu) 2000-05-28
HUP9904030A3 HUP9904030A3 (en) 2000-07-28

Family

ID=8097971

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904030A HUP9904030A3 (en) 1996-07-31 1997-07-25 Use of tiagabine for production of pharmaceutical against psychotic disorders

Country Status (18)

Country Link
US (1) US5914333A (hu)
EP (1) EP0920316B1 (hu)
JP (1) JP2000515156A (hu)
KR (1) KR20000029525A (hu)
CN (1) CN1226828A (hu)
AT (1) ATE330604T1 (hu)
AU (1) AU728191B2 (hu)
BR (1) BR9710893A (hu)
CA (1) CA2260863C (hu)
CZ (1) CZ29899A3 (hu)
DE (1) DE69736180T2 (hu)
ES (1) ES2268732T3 (hu)
HU (1) HUP9904030A3 (hu)
IL (1) IL128028A0 (hu)
NO (1) NO990450L (hu)
PL (1) PL331321A1 (hu)
WO (1) WO1998005330A1 (hu)
ZA (1) ZA976854B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
EP0991409B1 (en) * 1997-08-01 2002-01-30 ELAN CORPORATION, Plc Controlled release pharmaceutical compositions containing tiagabine
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
DE60035232T2 (de) * 1999-07-01 2008-02-14 Pharmacia & Upjohn Co. Llc, Kalamazoo (S,S)-Reboxetin zur Behandlung von chronischem Müdigkeits-Syndrom
US6270438B1 (en) * 1999-12-22 2001-08-07 Yuan-Cheng Liao Combination driving hub for bicycle
WO2005000294A1 (en) * 2003-06-06 2005-01-06 Pharmacia Corporation Selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders
US20090139311A1 (en) 2007-10-05 2009-06-04 Applied Biosystems Inc. Biological Analysis Systems, Devices, and Methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383999A (en) * 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5750140A (en) * 1994-05-20 1998-05-12 Novo Nordisk A/S Transdermal delivery of tiagabine
US5767117A (en) * 1994-11-18 1998-06-16 The General Hospital Corporation Method for treating vascular headaches
JP3195360B2 (ja) * 1995-05-05 2001-08-06 ノボ ノルディスク アクティーゼルスカブ チアガビン塩酸塩を含有する医薬組成物およびその製法
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
UA52661C2 (uk) * 1996-06-14 2003-01-15 Ново Нордіск А/С Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
DK174041B1 (da) * 1998-11-26 2002-05-06 Monarflex As Gennemføring til montering i en fleksibel membran

Also Published As

Publication number Publication date
ES2268732T3 (es) 2007-03-16
WO1998005330A1 (en) 1998-02-12
BR9710893A (pt) 1999-08-17
PL331321A1 (en) 1999-07-05
NO990450D0 (no) 1999-01-29
CN1226828A (zh) 1999-08-25
IL128028A0 (en) 1999-11-30
ZA976854B (en) 1998-03-19
KR20000029525A (ko) 2000-05-25
CA2260863C (en) 2008-02-12
AU3619797A (en) 1998-02-25
DE69736180T2 (de) 2007-06-14
DE69736180D1 (de) 2006-08-03
EP0920316B1 (en) 2006-06-21
EP0920316A1 (en) 1999-06-09
CA2260863A1 (en) 1998-02-12
HUP9904030A3 (en) 2000-07-28
US5914333A (en) 1999-06-22
AU728191B2 (en) 2001-01-04
JP2000515156A (ja) 2000-11-14
ATE330604T1 (de) 2006-07-15
CZ29899A3 (cs) 1999-06-16
NO990450L (no) 1999-01-29

Similar Documents

Publication Publication Date Title
CO5271691A1 (es) Nuevos compuestos
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
BR0109650A (pt) 3-cianoquinolinas, 3-ciano-1,6-naftiridinas e 3-ciano-1,7-naftiridinas como inibidores da cinase proteìca
TR200302214T4 (tr) Psoriasis tedavisi için kullanilan pteridine bileşkenleri
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
NO306464B1 (no) Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter
MX9707453A (es) Derivados de quinazolina.
BG66094B1 (bg) Азабициклени съединения, тяхното получаване и използване като лекарствени средста, по-специално като антибактериални средства
MY128659A (en) Novel aminodicarboxylic acid derivatives having pharmaceutical properties
NO985711D0 (no) Farmas°ytikum for behandling av neurologiske og neuropsykiatriske mangler
CY1111504T1 (el) Αζαδικυκλοαλκανια ως ρυθμιστες του ccr5
PT863875E (pt) Novos compostos 4-(oxialcoxifenil)-3-oxi-piperidina para o tratamento de insuficiencia cardiaca e renal
SE9903544D0 (sv) Novel compounds
ATE272398T1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
DE60233251D1 (de) 4,4-difluor-1,2,3,4-tetrahydro-5h-1-benzazepinderivate und deren salze
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
CO4410330A1 (es) Nuevos derivados de bencimidazol farmacologicamente activos y sus sales de adicion acida
HUP9904030A2 (hu) Tiagabin felhasználása pszichotikus rendellenességek kezelésére alkalmas gyógyszer előállítására
TR200103457T2 (tr) 4-Fenil-Pirimidin Türevleri.
DE60128100D1 (de) Analgetisches arzneimittel
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
BR9805437A (pt) Derivados de benzocicloalquenos heterocìclicos, processo para fabricação de derivados de benzocicloalquenos heterocìclicos e uso de derivados de benzocicloalquenos heterocìclicos.
BR9814188A (pt) "agonistas de 5-ht1f"
PT855398E (pt) Derivados sasquiterpeno tendo actividade antiviral